<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03560440</url>
  </required_header>
  <id_info>
    <org_study_id>S56779</org_study_id>
    <nct_id>NCT03560440</nct_id>
  </id_info>
  <brief_title>Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients</brief_title>
  <official_title>Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this retrospective registry the investigators wish to verify whether the current dosing
      regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric
      patients. Therefore data will be collected from all pediatric patients hospitalized in
      University Hospitals Leuven between January 2012 and April 2014 who were treated with
      vancomycine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this retrospective registry the investigators wish to verify whether the current dosing
      regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric
      patients. Therefore data will be collected from all pediatric patients hospitalized in
      University Hospitals Leuven between January 2012 and April 2014 who were treated with
      vancomycine. Patient files will be screened for relevant information. Individual patients can
      be included multiple times if vancomycin has been administered more than once.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Loading dose related plasma exposure vancomycin</measure>
    <time_frame>24 hours after loading dose</time_frame>
    <description>Plasma exposure to vancomycin in relation to administered dose</description>
  </primary_outcome>
  <other_outcome>
    <measure>Loading dose related plasma exposure vancomycin</measure>
    <time_frame>24 hours after dosage adjustment</time_frame>
    <description>Plasma exposure to vancomycin in relation to administered dose</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">368</enrollment>
  <condition>Gram-Positive Bacterial Infections</condition>
  <arm_group>
    <arm_group_label>Plasma exposure vancomycin</arm_group_label>
    <description>Pediatric patients treated with vancomycin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plasma exposure vancomycin</intervention_name>
    <description>Investigation of plasma exposure of vancomycin.</description>
    <arm_group_label>Plasma exposure vancomycin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients treated with vancomycin and hospitalized in UZ Leuven between January
        2012 and April 2014
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients hospitalized in the University Hospitals Leuven between January
             2012 and April 2014, treated with vancomycin

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabel Spriet, PharmD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.</citation>
    <PMID>19569969</PMID>
  </reference>
  <reference>
    <citation>Piro CC, Crossno CL, Collier A, Ho R, Koyama T, Frangoul H. Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. J Pediatr Hematol Oncol. 2009 Jan;31(1):3-7. doi: 10.1097/MPH.0b013e31818b3520.</citation>
    <PMID>19125078</PMID>
  </reference>
  <reference>
    <citation>Glover ML, Cole E, Wolfsdorf J. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care. 2000 Mar;15(1):1-4.</citation>
    <PMID>10757191</PMID>
  </reference>
  <reference>
    <citation>Kim DI, Im MS, Choi JH, Lee J, Choi EH, Lee HJ. Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients. Korean J Pediatr. 2010 Dec;53(12):1000-5. doi: 10.3345/kjp.2010.53.12.1000. Epub 2010 Dec 31.</citation>
    <PMID>21253314</PMID>
  </reference>
  <reference>
    <citation>Ito H, Shime N, Kosaka T. Pharmacokinetics of glycopeptide antibiotics in children. J Infect Chemother. 2013 Apr;19(2):352-5. doi: 10.1007/s10156-012-0458-8. Epub 2012 Aug 8.</citation>
    <PMID>22872188</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>November 29, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 6, 2018</last_update_submitted>
  <last_update_submitted_qc>June 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Isabelle Spriet</investigator_full_name>
    <investigator_title>PharmD PhD</investigator_title>
  </responsible_party>
  <keyword>Vancomycin</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Trough level</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Gram-Positive Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

